Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai 400056, India.
PK-PD Toxicology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India.
Int J Pharm. 2022 Oct 15;626:122144. doi: 10.1016/j.ijpharm.2022.122144. Epub 2022 Aug 25.
The cellulose-based polymers are extensively employed in oral formulations for addressing ADMET issues of API. Herein, we report the synergistic effect of hydroxyethyl cellulose in solubility/dissolution enhancement of BCS class II, anthelmintic drug niclosamide. The low solubility and poor oral bioavailability are the primary reasons for its high daily dose. The amorphous solid dispersions (ASDs) developed herein demonstrated reproducible solubility and dissolution enhancement in smaller-to-pilot batches. The significant boost in niclosamide solubility in HEC-based binary SD was rationalized as a result of intermolecular H-bonding as indicated by in-silico studies and further supported by characterization data. HEC is plausibly inhibiting the precipitation of drug and thereby enabling high dissolution and permeation across the membrane. The comparative oral pharmacokinetics in Wistar rats at 25 mg/kg provided 4.4-fold higher plasma exposure of niclosamide in SD formulation SB-ASD-N2 over the plain drug. The results presented herein warrant validation of this ASD under clinical settings.
基于纤维素的聚合物在口服制剂中被广泛用于解决 API 的 ADMET 问题。在此,我们报告了羟乙基纤维素在提高驱虫药硝氯酚(BCS Ⅱ类药物)溶解度/溶解速率方面的协同作用。低溶解度和差的口服生物利用度是其高日剂量的主要原因。本文所开发的无定形固体分散体(ASD)在较小规模到中试批次中显示出了重现性的溶解度和溶解速率提高。HEC 基二元 SD 中硝氯酚溶解度的显著提高可归因于分子间氢键,这一点通过计算机模拟研究得到了证实,并得到了表征数据的进一步支持。HEC 可能抑制了药物的沉淀,从而实现了高溶解速率和跨膜渗透。在 25mg/kg 剂量下,Wistar 大鼠的比较口服药代动力学研究表明,SD 制剂 SB-ASD-N2 中的硝氯酚的血浆暴露量比普通药物高 4.4 倍。本文的结果证明了这种 ASD 在临床环境下的验证是合理的。